Prasad Krishna, Revaiah Pruthvi C, Santosh Vemuri Krishna, Barwad Parag
Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India.
Eur Heart J Case Rep. 2020 Nov 5;4(6):1-6. doi: 10.1093/ehjcr/ytaa357. eCollection 2020 Dec.
Antineutrophil cytoplasmic antibody (ANCA)-associated pulmonary renal vasculitis is an uncommon disease entity. Its presentation as acute heart failure for the first time in a patient with established coronary artery disease (CAD) is even rarer. We present here a case of such an association and an approach to managing this clinical situation.
A 60-year-old male patient presented to the emergency room with recent-onset dyspnoea New York Heart Association Class IV. He was having hypertension, uncontrolled diabetes mellitus, chronic kidney disease (CKD), and CAD. He also underwent a percutaneous coronary intervention to left anterior descending in the past for acute coronary syndrome and had moderate left ventricular dysfunction. He was being managed as a case of acute decompensated heart failure (ADHF) and was mechanically ventilated. Suddenly his ventilator requirement increased and endotracheal aspirate contained blood. The chest radiograph showed bilateral hilar infiltrates. Simultaneously he also had recurrent episodes of ventricular tachycardia (VT) requiring direct current (DC) cardioversion. Blood investigations showed deranged renal function and severe hyperkalaemia, but no evidence of coagulopathy. High-resolution computed tomography chest showed features of diffuse alveolar haemorrhage. Further investigations revealed high titres of c-ANCA and raised inflammatory biomarkers. A diagnosis of ANCA-associated vasculitis presenting as acute on CKD with dyselectrolytaemia (hyperkalaemia) leading to VT was made. Apart from standard management for associated illness, he was treated with plasma exchange, steroids, and cyclophosphamide to which he responded and was later on discharged.
Antineutrophil cytoplasmic antibody-related pulmonary renal vasculitis can lead to rapidly progressing renal failure and may present as ADHF in a patient with existent CAD. The associated VT storm in our patient can be attributed to hyperkalaemia secondary to acute renal failure. A multidisciplinary approach is required for the successful management of such a complex clinical scenario.
抗中性粒细胞胞浆抗体(ANCA)相关的肺肾血管炎是一种罕见的疾病实体。在已确诊冠状动脉疾病(CAD)的患者中首次表现为急性心力衰竭的情况更为罕见。我们在此介绍这样一例关联病例以及处理这种临床情况的方法。
一名60岁男性患者因近期出现的呼吸困难(纽约心脏病协会IV级)就诊于急诊室。他患有高血压、未控制的糖尿病、慢性肾脏病(CKD)和CAD。他既往因急性冠状动脉综合征接受过左前降支经皮冠状动脉介入治疗,并有中度左心室功能障碍。他当时被作为急性失代偿性心力衰竭(ADHF)病例进行管理,且接受机械通气。突然,他对呼吸机的需求增加,气管内吸出物含有血液。胸部X线片显示双侧肺门浸润。同时,他还反复出现室性心动过速(VT)发作,需要直流电(DC)复律。血液检查显示肾功能紊乱和严重高钾血症,但无凝血功能障碍证据。胸部高分辨率计算机断层扫描显示弥漫性肺泡出血特征。进一步检查发现c-ANCA高滴度以及炎症生物标志物升高。诊断为ANCA相关血管炎,表现为CKD急性发作并伴有电解质紊乱(高钾血症)导致VT。除了对相关疾病的标准治疗外,他接受了血浆置换、类固醇和环磷酰胺治疗,治疗后有反应,随后出院。
抗中性粒细胞胞浆抗体相关的肺肾血管炎可导致快速进展的肾衰竭,并可能在已有CAD的患者中表现为ADHF。我们患者中相关的VT风暴可归因于急性肾衰竭继发的高钾血症。对于成功处理这种复杂的临床情况,需要多学科方法。